Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2014
05/27/2014US8735396 Benzofuranyl derivatives
05/27/2014US8735395 Protease inhibitors
05/27/2014US8735394 Combinations and modes of administration of therapeutic agents and combination therapy
05/27/2014US8735393 Anhydrous topical skin preparations
05/27/2014US8735392 Crystalline (8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one tosylate salt
05/27/2014US8735391 Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
05/27/2014US8735390 Polymorphs and salts
05/27/2014US8735389 Treating psychological conditions using muscarinic receptor M1 antagonists
05/27/2014US8735388 Heterocyclic compounds with affinity to muscarinic receptors
05/27/2014US8735387 Oxazolopyrimidines as Edg-1 receptor agonists
05/27/2014US8735385 Substituted phenyl cycloalkyl pyrrolidine (piperidine) spirolactams and amides, preparation and therapeutic use thereof
05/27/2014US8735384 Amino heteroaryl compounds as beta-secretase modulators and methods of use
05/27/2014US8735383 Glycine transporter-1 inhibitors
05/27/2014US8735382 Infusion and injection solution of levodopa
05/27/2014US8735381 Progesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer, etc
05/27/2014US8735380 Ulipristal acetate tablets
05/27/2014US8735379 Fatty acid acetylated salicylates and their uses
05/27/2014US8735378 Fatty acid acetylated salicylates and their uses
05/27/2014US8735377 Methods of treating herpes zoster
05/27/2014US8735376 Carbonate prodrugs and methods of using the same
05/27/2014US8735375 Therapeutic compositions
05/27/2014US8735374 Oral mucoadhesive dosage form
05/27/2014US8735373 Glycosaminoglycan oral use and compositions
05/27/2014US8735372 Nucleoside phosphoramidate prodrugs
05/27/2014US8735364 Antisense modulation of apolipoprotein B expression
05/27/2014US8735363 Preparation and application of heparin silver
05/27/2014US8735356 Anticonvulsant combination therapy
05/27/2014US8735343 Product and process for liquefaction of mucus or sputum
05/27/2014US8735321 Process for the production of particles comprising active agrochemical ingredients in amorphous form
05/27/2014US8735145 Property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses
05/27/2014US8735071 Compositions for promoting epigenetic DNA demethylation and methods of use therefore
05/27/2014US8734869 Synergistic pest-control compositions
05/27/2014US8734865 Lupin total extract consisting of a lupin sugar extract and a lupin peptide extract, method for the production and use thereof
05/27/2014US8734855 Slow release magnesium composition and uses thereof
05/27/2014US8734853 HDL particles for delivery of nucleic acids
05/27/2014US8734852 Parenteral controlled release formulations of NSAID's
05/27/2014US8734850 Oral medicinal product with modified release of at least one active principle in multimicrocapsular form
05/27/2014US8734847 Formulation of indomethacin
05/27/2014US8734843 Medicament sustained-release particles and method for preparing the same
05/27/2014US8734839 Liquid compositions for soft sustained-release capsules and method for production
05/27/2014US8734838 Adhesive containing polyisoprene, sis copolymer, and solid/liquid polyisobutylene for external use on skin
05/27/2014US8734836 Methods and compositions for applying pharmacologic agents to the ear
05/27/2014US8734830 Manufacturing method and apparatus of ultrafine particles having uniform particle size distribution
05/27/2014US8734819 Animal-repelling synthetic resin composition
05/27/2014US8734817 Hyaluronic acid based copolymers
05/27/2014US8734780 Methods for treating cardiac pacing conditions
05/27/2014US8734777 Heterocyclic antiviral compounds
05/27/2014US8734772 Photo-curable resin for cosmetic application
05/27/2014US8734770 Methods and compositions for administration of TRPV1 agonists
05/27/2014US8734769 1L1RL-1 as a cardiovascular disease marker and therapeutic target
05/27/2014CA2804124C Cannabis drug delivery and monitoring system
05/27/2014CA2792234C 2,3 dihydro-1h-inden-1-yl-2,7-diazaspiro [3.5] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor
05/27/2014CA2766388C Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
05/27/2014CA2758986C Inhibitors of pi3 kinase and/or mtor
05/27/2014CA2752738C Small molecule inhibitors of mdm2 and uses thereof
05/27/2014CA2729578C Phenanthrenone compounds, compositions and methods
05/27/2014CA2725441C Indoles as modulators of nicotinic acetylcholin receptor subtype alpha-71
05/27/2014CA2712614C Combination therapy comprising sglt inhibitors and dpp4 inhibitors
05/27/2014CA2710579C Beverage comprising arginine
05/27/2014CA2707349C Organic compounds useful as inhibitors of phosphodiesterase 1
05/27/2014CA2699718C Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus
05/27/2014CA2696632C High concentration local anesthetic formulations
05/27/2014CA2678495C Disinfectant composition including quaternary ammonium salt and alkanolamine
05/27/2014CA2678424C Percutaneous administration device of bisoprolol
05/27/2014CA2666512C Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability
05/27/2014CA2660637C Phenylalkyl n-hydroxyureas for combating atherosclerotic plaque
05/27/2014CA2658395C Pharmaceutically acceptable solubilizing composition and pharmaceutical dosage form containing same
05/27/2014CA2658313C Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
05/27/2014CA2656229C Improvements relating to biocidal compositions
05/27/2014CA2650382C Diketo-piperazine and piperidine derivatives as antiviral agents
05/27/2014CA2647803C Combination comprising a) a pyrimidylaminobenzamide compound, and b) a thr315lle kinase inhibitor
05/27/2014CA2642598C Selective androgen receptor modulators
05/27/2014CA2633701C Novel, acyclically substitued furopyrimidine derivatives and use thereof
05/27/2014CA2633243C Azepinoindole derivatives as pharmaceutical agents
05/27/2014CA2631949C Micronization method for preparing virtually anhydrous tiotropium bromide monohydrate
05/27/2014CA2631876C Aminophenyl derivatives as inhibitors of histone deacetylase
05/27/2014CA2629132C Pyrimidylaminobenzamide derivatives for the treatment of neurofibromatosis
05/27/2014CA2626615C Preventing diseases in infants delivered via caesarean section
05/27/2014CA2624829C Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
05/27/2014CA2623770C Pyridopyrimidinone inhibitors of pi3k.alpha.
05/27/2014CA2622352C Substituted pyrazole compounds
05/27/2014CA2621292C 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity
05/27/2014CA2621228C Isoxazoline-substituted benzamide compound and pesticide
05/27/2014CA2620534C Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicaments
05/27/2014CA2618723C Bis(thio-hydrazide amide) formulation
05/27/2014CA2617920C Argatroban formulation comprising an acid as solubilizer
05/27/2014CA2617817C Thiazole derivatives for treating or preventing sleep disorders
05/27/2014CA2615726C Indol-3-yl-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists
05/27/2014CA2609188C Apo-2 ligand/trail formulations
05/27/2014CA2606550C Piperidine-substituted indoles
05/27/2014CA2605144C Substituted cyclic urea derivatives and the use thereof as vanilloid receptor 1 modulators
05/27/2014CA2604805C Pyrrolobenzodiazepines
05/27/2014CA2603654C Crystalline hydrochloride salt of a quinolinone-carboxamide compound or a solvate thereof
05/27/2014CA2601028C Flavonoid compounds and uses thereof
05/27/2014CA2598423C Antibacterial piperidine derivatives
05/27/2014CA2598087C 5-[4-(4-(2-amino-2 methoxycarbonylethyl)phenoxy)benzilidene]thiazolidin-2,4-dione derivatives and related compounds for reducing glucose, cholesterol and triglyceride levels in plasma
05/27/2014CA2597255C Natural ligand of g protein coupled receptor rcc356 and uses thereof
05/27/2014CA2588708C Use of lipoic acid to improve immune response by increased natural killer cell activity
05/27/2014CA2584664C (biphenyl) carboxylic acids and derivatives thereof
05/27/2014CA2577301C Substituted biaryl piperazinyl-pyridine analogues
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 7860